Nanoscope Therapeutics0 Like PostComments Off on Ophthalmology Times: Nanoscope Therapeutics announces FDA clearance of IND for MCO-010 gene therapy in Stargardt patients
Nanoscope Therapeutics0 Like PostComments Off on Ft Worth Business Press: TechFW Client Nanoscope Receives $1.5M Grant to Move Macular Degeneration Therapy Forward
Nanoscope Therapeutics0 Like PostComments Off on Dallas Innovates: Nanoscope Awarded $1.5 Million Grant for Eyesight Gene Therapy as it ‘Takes Steps to Go Public’
Nanoscope Therapeutics0 Like PostComments Off on Fort Worth Business Press: First patient receives innovative gene therapy eye treatment from TechFW client
Nanoscope Therapeutics0 Like PostComments Off on Fighting Blindness Foundation: Nanoscope Therapeutics Launches Phase 2b Clinical Trial for Optogenetic Therapy
Nanoscope Therapeutics0 Like PostComments Off on BioSpace: Nanoscope Therapeutics Announces FDA Approval of IND for Phase 2b Clinical Trial of Optogenetic Gene Monotherapy to Restore Vision in Patients with RP
Nanoscope Therapeutics0 Like PostComments Off on Ft. Worth Business Press: Nanoscope Therapeutics cleared to open Phase 2b clinical trial for vision therapy
Nanoscope Therapeutics0 Like PostComments Off on Dallas Morning News: Bedford biotech’s eyesight-restoring gene therapy received FDA approval to test in the U.S.
Nanoscope Therapeutics0 Like PostComments Off on Dallas Innovates: Bedford Biotech Restores “Meaningful Vision” in Blind Patients With Gene Therapy—and May Soon Go Public
Nanoscope Therapeutics0 Like PostComments Off on Dallas Morning News: Bedford Biotech’s Gene Therapy Improves Sight for 11 Patients with Rare Genetic Retinal Disorder
Nanoscope Therapeutics0 Like PostComments Off on Citybiz: Nanoscope’s Optogenetic Gene Therapy Restores Clinically Meaningful Vision in 11 Patients Blinded by Retinitis Pigmentosa
This website uses cookies to improve your experience. By clicking "Accept", you consent to the use of ALL the cookies. However you may visit the Cookie Settings to provide a controlled consent. Cookie settingsAccept
Cookies Policy
Privacy Overview
This website uses cookies to improve your experience while you navigate through the website. Out of these cookies, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may have an effect on your browsing experience.
